Welcome to NGC. Skip directly to: Search Box, Navigation, Content.


Brief Summary

GUIDELINE TITLE

Stroke: 2005 International Consensus Conference on Cardiopulmonary Resuscitation and Emergency Cardiovascular Care Science with Treatment Recommendations.

BIBLIOGRAPHIC SOURCE(S)

  • Stroke. In: 2005 International Consensus Conference on Cardiopulmonary Resuscitation and Emergency Cardiovascular Care Science with Treatment Recommendations. Circulation 2005 Nov 29;112(22 Suppl):III110-4. [69 references]

GUIDELINE STATUS

This is the current release of the guideline.

BRIEF SUMMARY CONTENT

 
RECOMMENDATIONS
 EVIDENCE SUPPORTING THE RECOMMENDATIONS
 IDENTIFYING INFORMATION AND AVAILABILITY
 DISCLAIMER

 Go to the Complete Summary

RECOMMENDATIONS

MAJOR RECOMMENDATIONS

Out-of-Hospital Setting

Once the stroke victim is identified, transport and triage are important decisions that require the participation of hospitals and community notification. Each receiving hospital should define its capabilities for treating patients with acute stroke and should communicate this information to the emergency medical services (EMS) system and the community.

Oxygen

Administration of supplementary oxygen to hypoxemic stroke patients by out-of-hospital and in-hospital medical personnel is recommended. Because there is conflicting evidence regarding the benefits of supplementary oxygen administration to normoxemic stroke patients, healthcare professionals may consider giving oxygen to these stroke patients on an individual basis.

Out-of-Hospital Stroke Assessment Tools

EMS systems must provide education and training to minimize delays in prehospital dispatch, assessment, and transport. With training in the use of relatively simple stroke assessment tools, prehospital providers can identify potential victims of stroke with high sensitivity and specificity.

Paramedics should be trained in the recognition of stroke with a validated, abbreviated out-of-hospital neurologic evaluation tool such as the Cincinnati Prehospital Stroke Scale or the Los Angeles Prehospital Stroke Screen.

Prehospital Triage

Initial low-level evidence indicates a favorable benefit from triage of stroke patients to designated stroke centers, but this concept should be explored using more rigorous levels of evidence.

Fibrinolytic Therapy

Intravenous (IV) Fibrinolytics

In the setting of a clearly defined protocol, a knowledgeable stroke team, and institutional commitment, IV administration of tissue plasminogen activator (tPA) to patients with acute ischemic stroke who meet the National Institute of Neurological Disorders and Stroke (NINDS) eligibility criteria is recommended. There is strong evidence to avoid all delays and treat patients as soon as possible.

Although not every hospital is capable of organizing the necessary resources to safely administer fibrinolytic therapy, every hospital with an emergency department should have a written plan describing how patients with acute stroke are to be managed in that institution. The plan should detail the roles of healthcare professionals in the care of patients with acute stroke and define which patients will be treated with fibrinolytic therapy at that facility and when transfer to another hospital with a dedicated stroke unit is appropriate. Emergent computerized tomography (CT) or magnetic resonance imaging (MRI) scans of patients with suspected acute stroke should be reviewed quickly by a physician who is expert in the interpretation of those studies.

Intra-Arterial Fibrinolytics

For patients with acute ischemic stroke who are not candidates for standard IV fibrinolysis, administration of intraarterial fibrinolysis in centers that have the resources available may be considered within the first 6 hours after the onset of symptoms.

In-Patient Care

Stroke Units

Hospitalized stroke patients experience improved outcomes when cared for by a multidisciplinary team experienced in managing stroke. Thus, when it is available, stroke patients who require hospitalization should be admitted to a stroke unit.

Glucose Control

For consistency with the American Stroke Association (Adams et al., 2005; Adams et al., 2003) and the European Stroke Initiative Guidelines (Klijn & Hankey, 2003), administration of IV or subcutaneous insulin may be considered for patients with acute ischemic stroke in the in-hospital setting to lower blood glucose when the serum glucose level is >10 mmol/L (about 200 mg/dL).

Therapeutic Hypothermia

There is insufficient scientific evidence to recommend for or against the routine use of hypothermia in the treatment of acute ischemic stroke (Class Indeterminate).

CLINICAL ALGORITHM(S)

None provided

EVIDENCE SUPPORTING THE RECOMMENDATIONS

REFERENCES SUPPORTING THE RECOMMENDATIONS

TYPE OF EVIDENCE SUPPORTING THE RECOMMENDATIONS

The type of evidence supporting the recommendations is not specifically stated

IDENTIFYING INFORMATION AND AVAILABILITY

BIBLIOGRAPHIC SOURCE(S)

  • Stroke. In: 2005 International Consensus Conference on Cardiopulmonary Resuscitation and Emergency Cardiovascular Care Science with Treatment Recommendations. Circulation 2005 Nov 29;112(22 Suppl):III110-4. [69 references]

ADAPTATION

Not applicable: The guideline was not adapted from another source.

DATE RELEASED

2005 Nov 29

GUIDELINE DEVELOPER(S)

American Heart Association - Professional Association

SOURCE(S) OF FUNDING

American Heart Association

GUIDELINE COMMITTEE

International Liaison Committee on Resuscitation (ILCOR)

COMPOSITION OF GROUP THAT AUTHORED THE GUIDELINE

Not stated

FINANCIAL DISCLOSURES/CONFLICTS OF INTEREST

GUIDELINE STATUS

This is the current release of the guideline.

GUIDELINE AVAILABILITY

Electronic copies: Available from the American Heart Association Web site.

Print copies: Available from the American Heart Association, Public Information, 7272 Greenville Ave, Dallas, TX 75231-4596; Phone: 800-242-8721

AVAILABILITY OF COMPANION DOCUMENTS

The following are available:

  • Introduction. 2005 International Consensus Conference on Cardiopulmonary Consensus Conference on Cardiopulmonary Resuscitation and Emergency Cardiovascular Care Science with Treatment Recommendations. Circulation 2005 Nov 29;112(22 Supplement):III-1-III-4.
  • The evidence evaluation process for the 2005 International Consensus Conference on Cardiopulmonary Resuscitation and Emergency Cardiovascular Care Science with Treatment Recommendations. Circulation 2005 Nov 29;112(22 Supplement):III-128-III-130.
  • Conflict of interest management before, during, and after the 2005 International Consensus Conference on Cardiopulmonary Resuscitation and Emergency Cardiovascular Care Science with Treatment Recommendations. Circulation 2005 Nov 29;112(22 Supplement):III-131-III-132.
  • Controversial topics from the 2005 International Consensus Conference on Cardiopulmonary Resuscitation and Emergency Cardiovascular Care Science with Treatment Recommendations. Circulation 2005 Nov 29;112(22 Supplement):III-133-III-136.
  • Appendix 1: Worksheet topics and authors. Circulation 2005 Nov 29;112(22 Supplement):B1-B14.
  • Appendix 3: Conflict of interest for editors, editorial board, special contributors and reviewers, and honorees. Circulation 2005 Nov 29;112(22 Supplement):B16-B18.
  • 2005 International Consensus Conference on Cardiopulmonary Resuscitation (CPR) and Emergency Cardiovascular Care (ECC) Science with Treatment Recommendations. Section 2: stroke and first aid. Circulation 2005 Nov 29;112(22 Supplement):III-109.

Electronic copies: Available from the American Heart Association Web site.

Print copies: Available from the American Heart Association, Public Information, 7272 Greenville Ave, Dallas, TX 75231-4596; Phone: 800-242-8721

PATIENT RESOURCES

None available

NGC STATUS

This NGC summary was completed by ECRI on February 6, 2006. The information was verified by the guideline developer on March 7, 2006.

COPYRIGHT STATEMENT

DISCLAIMER

NGC DISCLAIMER

The National Guideline Clearinghouse™ (NGC) does not develop, produce, approve, or endorse the guidelines represented on this site.

All guidelines summarized by NGC and hosted on our site are produced under the auspices of medical specialty societies, relevant professional associations, public or private organizations, other government agencies, health care organizations or plans, and similar entities.

Guidelines represented on the NGC Web site are submitted by guideline developers, and are screened solely to determine that they meet the NGC Inclusion Criteria which may be found at http://www.guideline.gov/about/inclusion.aspx .

NGC, AHRQ, and its contractor ECRI Institute make no warranties concerning the content or clinical efficacy or effectiveness of the clinical practice guidelines and related materials represented on this site. Moreover, the views and opinions of developers or authors of guidelines represented on this site do not necessarily state or reflect those of NGC, AHRQ, or its contractor ECRI Institute, and inclusion or hosting of guidelines in NGC may not be used for advertising or commercial endorsement purposes.

Readers with questions regarding guideline content are directed to contact the guideline developer.


 

 

   
DHHS Logo